Der er rapporteret om fremkomst af diabetes mellitus, hyperglykæmi eller forværringer af eksisterende diabetes mellitus hos patienter, der fik antiretroviral behandling inkl. proteasehæmmere.
New onset of diabetes mellitus, hyperglycaemia or exacerbations of existing diabetes mellitus has been reported in patients receiving antiretroviral therapy, including protease inhibitors.